Contribution of a rapid influenza diagnostic test to manage hospitalized patients with suspected influenza

Diagn Microbiol Infect Dis. 2017 Mar;87(3):238-242. doi: 10.1016/j.diagmicrobio.2016.11.015. Epub 2016 Nov 27.

Abstract

Aim: To evaluate the performances of the Alere i influenza A&B test and to appraise its contribution to patient management.

Methods: In total, 267 samples were tested. Influenza A and B PCR was performed as the reference. For each positive result, the supervising physician was contacted to collect data regarding patient management.

Findings: The overall sensitivity and specificity of the Alere i were 91.4% and 97.6% for influenza A and 54.5% and 98.8% for influenza B, respectively. More specifically, when used in the emergency room (ER), the test helped avoid 10.7% of hospitalizations, 46.4% of antibiotic prescriptions and 42.9% of additional investigations for positive patients. The test was also helpful in instituting the prescription of oseltamivir and patient isolation.

Conclusion: Alere i influenza A&B is a rapid, sensitive and specific diagnostic test for influenza A. Sensitivity for influenza B was poor. Its usefulness was more important when patients were still in the ER.

Keywords: Alere i; Clinical contribution; Diagnosis; Influenza; Sofia.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antiviral Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Diagnostic Tests, Routine / methods*
  • Disease Management
  • Female
  • Hospitalization
  • Humans
  • Infant
  • Infant, Newborn
  • Influenza A virus / genetics*
  • Influenza B virus / genetics*
  • Influenza, Human / diagnosis*
  • Influenza, Human / drug therapy*
  • Male
  • Middle Aged
  • Molecular Diagnostic Techniques / methods*
  • Nucleic Acid Amplification Techniques
  • Oseltamivir / therapeutic use*
  • Point-of-Care Systems
  • Reagent Kits, Diagnostic
  • Sensitivity and Specificity
  • Young Adult

Substances

  • Antiviral Agents
  • Reagent Kits, Diagnostic
  • Oseltamivir